Quotes 5-day view End-of-day quote Tokyo Stock Exchange
01/18/2021
01/19/2021
01/20/2021
01/21/2021
01/22/2021
Date
2820
2856
2841
2826
2778
Last
477800
625100
560300
502400
457800
Volume
+0.07% +1.28% -0.53% -0.53% -1.70% Change
Sales 2020
321 B 3 090 M 3 090 M
Net income 2020
48 127 M 464 M 464 M
Net cash position 2020
192 B 1 849 M 1 849 M
P/E ratio 2020
31,3x
Yield 2020
1,58%
Sales 2021
348 B 3 355 M 3 355 M
Net income 2021
57 027 M 549 M 549 M
Net cash position 2021
224 B 2 161 M 2 161 M
P/E ratio 2021
26,2x
Yield 2021
1,67%
Capitalization
1 492 B 14 378 M 14 378 M
EV / Sales 2020
4,05x
EV / Sales 2021
3,64x
Nbr of Employees
5 267
Free-Float
45,8%
Kyowa Kirin Co., Ltd. (formerly Kyowa Hakko Kirin Co., Ltd.) specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (94.1%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (5.9%).
At the end of 2019, the group had 3...
Notations Surperformance© of Kyowa Kirin Co., Ltd.
Trading Rating : Investor Rating :
All news about KYOWA KIRIN CO., LTD.
News in other languages on KYOWA KIRIN CO., LTD.
Chart KYOWA KIRIN CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends KYOWA KIRIN CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
12
Average target price
3 425,00 JPY
Last Close Price
2 778,00 JPY
Spread / Highest target
51,2%
Spread / Average Target
23,3%
Spread / Lowest Target
-2,81%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
